PRAZOSIN UPDATE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE HEART-FAILURE

被引:162
作者
STANASZEK, WF [1 ]
KELLERMAN, D [1 ]
BROGDEN, RN [1 ]
ROMANKIEWICZ, JA [1 ]
机构
[1] AUSTRALASIAN DRUG INFORMAT SERV, POB 34-030, AUCKLAND 10, NEW ZEALAND
关键词
D O I
10.2165/00003495-198325040-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:339 / 384
页数:46
相关论文
共 243 条
[1]  
AARYNEN M, 1981, ANN CLIN RES, V13, P71
[2]   LACK OF ANTAGONISM IN THE ANTIHYPERTENSIVE EFFECTS OF CLONIDINE AND PRAZOSIN IN MAN [J].
ANDREJAK, M ;
FIEVET, P ;
MAKDASSI, R ;
COMOY, E ;
DEFREMONT, JF ;
COEVOET, B ;
FOURNIER, A .
CLINICAL SCIENCE, 1981, 61 :S453-S455
[3]   PRAZOSIN IN HYPERTENSION WITH HEART-FAILURE [J].
ANTANI, JA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1979, 1 (06) :S56-S62
[4]  
ARMSTRONG PW, 1978, CLIN RES, V26, pA830
[5]   ATTENUATION OF PRAZOSIN EFFECT ON CARDIAC-OUTPUT IN CHRONIC HEART-FAILURE [J].
ARNOLD, SB ;
WILLIAMS, RL ;
PORTS, TA ;
BAUGHMAN, RA ;
BENET, LZ ;
PARMLEY, WW ;
CHATTERJEE, K .
ANNALS OF INTERNAL MEDICINE, 1979, 91 (03) :345-349
[6]   EFFECT OF PRAZOSIN VS PLACEBO ON CHRONIC LEFT-VENTRICULAR HEART-FAILURE [J].
ARONOW, WS ;
LURIE, M ;
TURBOW, M ;
WHITTAKER, K ;
VANCAMP, S ;
HUGHES, D .
CIRCULATION, 1979, 59 (02) :344-350
[7]  
AWAN NA, 1977, CLIN PHARMACOL THER, V22, P79
[8]   EFFICACY OF AMBULATORY SYSTEMIC VASODILATOR THERAPY WITH ORAL PRAZOSIN IN CHRONIC REFRACTORY HEART-FAILURE - CONCOMITANT RELIEF OF PULMONARY CONGESTION AND ELEVATION OF PUMP OUTPUT DEMONSTRATED BY IMPROVEMENTS IN SYMPTOMATOLOGY, EXERCISE TOLERANCE, HEMODYNAMICS AND ECHOCARDIOGRAPHY [J].
AWAN, NA ;
MILLER, RR ;
DEMARIA, AN ;
MAXWELL, KS ;
NEUMANN, A ;
MASON, DT .
CIRCULATION, 1977, 56 (03) :346-354
[9]  
AWAN NA, 1979, CIRCULATION, V60, P180
[10]   IMPORTANCE OF NEUROENDOCRINE REGULATORS OF VASCULAR TONE AND INTEGRAL ADRENORECEPTOR INTERACTION DURING ORAL VASODILATOR THERAPY OF SEVERE CONGESTIVE HEART-FAILURE WITH PRAZOSIN [J].
AWAN, NA ;
BEATTIE, JM ;
EVENSON, ME ;
NEEDHAM, KE ;
MASON, DT .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 :S176-S180